We are monitoring the impact of COVID-19 on MEA Drug Delivery Devices Market Get in touch with us for detailed analysis Know More
Pulished Date April, 2021
ID: 2256
Share on
Share on

Middle East & Africa Drug Delivery Devices Market Research Report – Segmented By Route Of Administration, Facility Of Use and Country (KSA, UAE, Israel, rest of GCC countries, South Africa, Ethiopia, Kenya, Egypt, Sudan, rest of MEA) - Industry Analysis, Size, Share, Trends & Growth Forecast (2021 to 2026)

Pulished: April, 2021
ID: 2256
Pages: 180

MEA Drug Delivery Devices Market Size (2021 to 2026)

The size of the Middle East and Africa market for Drug Delivery Technology is expected to reach USD 167.04 Million by 2026 from USD 114.74 Million in 2021, hiking at a CGAR of 7.832% during the forecast period.

The market for drug delivery devices in the MEA region is majorly driven by the growing prevalence of chronic disease and the rising acceptance of self-administering drugs. Also, the Growing geriatric population is more prone to various diseases; therefore, the geriatric population across the region is influencing the market growth. The overall market is anticipated to increase due to the increasing use of advanced technology for efficiently delivering the medication to the target site. Moreover, the rapid surge in chronic diseases such as cancer, respiratory diseases, cardiovascular diseases, and contagious diseases across the region is augmenting the market growth. The properties of nanoparticles have been studied and used to enhance drug delivery systems, making the process of medication distribution more efficient and time-saving. 

Additionally, by optimizing the medication present at the target location, these drug delivery systems minimize the reduction of side effects, lowering the dosage and related adverse effects. Also, lowering the number of active pharmaceutical ingredients helps to lower the total product price.

Technological advances in drug delivery devices are now being studied to make them more patient-friendly, accessible, and accurate. As a result, players are constantly inventing improved drug delivery systems and researching new technologies. Furthermore, advances in polymer science are aiding in the development of drug delivery devices. The development of such unique polymers will improve the precision with which drugs are delivered via devices. As a result, market growth is fuelled by technologically enhanced drug delivery devices throughout the forecast period.

On the other hand, an increasing number of clinical trials for the pandemic COVID-19 are escalating the drug delivery devices market. There are a large number of drugs and vaccines in various stages of clinical trials for treating COVID-19 that are expected to be launched in the future months or years under emergency management authorization guidelines. Furthermore, the COVID-19 pandemic is predicted to increase demand for medication delivery devices, particularly respiratory-based delivery systems. Oral and injectable drugs are utilized to treat COVID-19, although pulmonary or respiratory-based drug delivery systems are expected to have a minor increase.

However, the MEA drug delivery devices market growth is hampered by stringent government regulations connected with the introduction of novel drug delivery devices. 

This research report on the MEA Drug Delivery Devices Market segmented and sub-segmented into the following categories:

By Route of administration:

  • Oral Drug Delivery
  • Pulmonary Drug Delivery
  • Injectable Drug Delivery
  • Ocular Drug Delivery
  • Nasal Drug Delivery
  • Topical Drug Delivery
  • Implantable Drug Delivery
  • Tran mucosal Drug Delivery

By Facility of Use: 

  • Hospitals
  • Ambulatory Surgical Centers
  • Home Care settings
  • Diagnostic Centers

By Region: 

  • KSA
  • UAE
  • Israel
  • rest of GCC countries
  • South Africa
  • Ethiopia
  • Kenya
  • Egypt
  • Sudan
  • rest of MEA

Geographically, Middle East Africa is projected to account for a moderate share during the forecast period. An increase in the number of cancers, respiratory diseases, and diabetic patients throughout the MEA is likely to encourage the use of drug delivery devices and boost the total market. Also, the Increasing awareness of the benefits of medication delivery devices in the region is also likely to promote market growth in the region. The presence of Developing economies such as UAE, South Africa, and Saudi Arabia are major contributors to the regional market growth. In the regional market, South Africa dominated the market with a significant market share. The surge in the incidence of chronic diseases such as diabetes and cancer are other primary factors contributing to the growth of this market in South Africa. 

In addition, Saudi Arabia and UAE are most likely to account significant share during the forecast period. An increasing population with a prevalence of various chronic diseases is propelling the market growth. There has been a rising adoption and inclination towards improved medication delivery systems since they help deliver pharmaceuticals that are useful for the targeted population to recover faster.

KEY MARKET PLAYERS:

Companies playing a prominent role in the MEA Drug Delivery Devices Market profiled in the report are Bend Research, Endocyte, Microchips Inc., Pearl Therapeutics Inc., Presage Bioscience, UCB Group, Genentech Inc., Polymer Factory, Alkermes Inc., BIND Biosciences Inc., and QLT Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Route of administration                        

                                5.1.1 Introduction           

                                5.1.2 Oral Drug Delivery

                                5.1.3 Pulmonary Drug Delivery  

                                5.1.4 Inject able Drug Delivery   

                                5.1.5 Ocular Drug Delivery           

                                5.1.6 Nasal Drug Delivery             

                                5.1.7 Topical Drug Delivery          

                                5.1.8 Implantable Drug Delivery                

                                5.1.9 Tran mucosal Drug Delivery             

                                5.1.10  Y-o-Y Growth Analysis, By Route of administration            

                                5.1.11  Market Attractiveness Analysis, By Route of administration          

                                5.1.12  Market Share Analysis, By Route of administration            

                5.2 Facility of use                             

                                5.2.1 Introduction           

                                5.2.2 Hospitals  

                                5.2.3 Ambulatory Surgical Centers           

                                5.2.4 Home care settings             

                                5.2.5 Diagnostic Centers               

                                5.2.6 Others      

                                5.2.7 Y-o-Y Growth Analysis, By Facility of use    

                                5.2.8 Market Attractiveness Analysis, By Facility of use  

                                5.2.9 Market Share Analysis, By Facility of use    

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 Route of administration

                                                6.1.3.3 By Facility of use

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Route of administration

                                                6.1.4.3 By Facility of use

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Route of administration

                                                6.1.5.3 By Facility of use

                6.2 Middle-East                                

                6.3 Africa                            

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Bend Research                          

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Endocyte                     

                8.3 MicroCHIPS Inc                         

                8.4 Pearl Therapeutics Inc                           

                8.5 Presage Bioscience                 

                8.6 UCB Group                 

                8.7 Genentech Inc                          

                8.8 Polymer Factory                       

                8.9 Alkermes Inc                              

                8.10 BIND Biosciences Inc                            

                8.11 QLT Inc                       

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, collaborations and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organisations a strong financial foothold in the market
  1. Middle East & Africa Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Billion)
  2. Middle East & Africa Oral Drug Delivery Market, By Region, From 2021 to 2026 (USD Billion)
  3. Middle East & Africa Pulmonary Drug Delivery Market, By Region, From 2021 to 2026 (USD Billion)
  4. Middle East & Africa Injectable Drug Delivery  Market, By Region, From 2021 to 2026 (USD Billion)
  5. Middle East & Africa Ocular Drug Delivery  Market, By Region, From 2021 to 2026 (USD Billion)
  6. Middle East & Africa Nasal Drug Delivery Market, By Region, From 2021 to 2026 (USD Billion)
  7. Middle East & Africa Topical Drug Delivery  Market, By Region, From 2021 to 2026 (USD Billion)
  8. Middle East & Africa Implantable Drug Delivery  Market, By Region, From 2021 to 2026 (USD Billion)
  9. Middle East & Africa Tran mucosal Drug Delivery Market, By Region, From 2021 to 2026 (USD Billion)
  10. Middle East & Africa Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Billion)
  11. Middle East & Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  12. Middle East & Africa Ambulatory Surgical Centers Market, By Region, From 2021 to 2026 (USD Billion)
  13. Middle East & Africa Home Care settings Market, By Region, From 2021 to 2026 (USD Billion)
  14. Middle East & Africa Diagnostic Centers Market, By Region, From 2021 to 2026 (USD Billion)
  15. Middle East & Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  16. Middle East Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Billion)
  17. Middle East Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Billion)
  18. Africa Drug Delivery Devices Market, By Route of administration, From 2021 to 2026 (USD Billion)
  19. Africa Drug Delivery Devices Market, By Facility of use, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 2875

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample